Trial · NCT03485950
Trial comparisons26
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 26
Download this page as JSON| Comparison | Source |
|---|---|
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the mMITT Analysis Set at Late Follow-Up (LFU) | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Infection-related Mortality in the MITT Analysis Set at LFU | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the ME Analysis Set at LFU. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Infection-related Mortality in the mMITT Analysis Set at LFU. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the ME Analysis Set at TOC | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Microbiological Response in the mMITT Analysis Set at LFU. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the MITT Analysis Set at TOC | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the CE Analysis Set at LFU. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: 30 Day All-cause Mortality in the MITT Analysis Set | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response at End of Inpatient Intravenous Therapy (EOIV) | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the Clinically Evaluable (CE) Analysis Set at EOIV. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the mMITT Analysis Set at Test of Cure (TOC) | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: 30 Day All-cause Mortality in the mMITT Analysis Set | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Infection-related Mortality in the MITT Analysis Set at TOC | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Favorable Microbiological Response in the mMITT Analysis Set at TOC. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the ME Analysis Set at EOIV. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the Microbiological Modified Intent-to-treat (mMITT) Analysis Set at EOIV. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Clinical Response in the MITT Analysis Set at Late Follow-Up (LFU) | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Microbiological Response in the ME Analysis Set at EOIV. | Trial comparisons |
| Ceftolozane/Tazobactam Arm vs Standard of Care (SOC) Arm: Number of Participants With Favorable Microbiological Response in the mMITT Analysis Set at EOIV. | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03485950/comparisons